A Family of Synergistic
Precigen is focused on improving patient care through innovative gene and cell therapies. Our subsidiaries are an important part of realizing this mission as they are advancing a portfolio of unique solutions to address unmet needs in health.
Pioneering a new class of microbe-based pharmaceutical agents through its ActoBiotics™ platform for expression and local delivery of therapeutics at disease sites including the intestine, the mouth and the nasopharynx to treat a range of disorders
Enabling discovery by providing porcine research models and services that aid scientists in the understanding of human disease mechanisms, development of new therapeutics, development of next-generation medical procedures and devices, and optimization of novel diagnostics